$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
来那替尼联合坦西莫司治疗肺癌的效果
2025-10-19 11:44:20
Check Details
特罗凯和阿法替尼治疗肺鳞癌的数据
2025-10-19 11:44:20
Check Details
克唑替尼使中国肺癌患者获益
2025-10-19 11:44:20
Check Details
克唑替尼治疗ROS1阳性的晚期NSCLC
2025-10-19 11:44:20
Check Details
色瑞替尼使ALK重排的NSCLC患者获益
2025-10-19 11:44:20
Check Details
ALK阳性NSCLC患者的靶向治疗
2025-10-19 11:44:20
Check Details
易瑞沙对不同肺癌治疗效果不同
2025-10-19 11:44:20
Check Details
ALK阳性肺癌患者靶向药物艾乐替尼
2025-10-19 11:44:20
Check Details
色瑞替尼联合紫杉醇治疗非小细胞肺癌
2025-10-19 11:44:20
Check Details
帕唑帕尼治疗非小细胞肺癌
2025-10-19 11:44:20
Check Details
克唑替尼在IHC检测ALK重排肺腺癌患者中的临床疗效研究
2025-10-19 11:44:20
Check Details
阿法替尼与吉非替尼治疗非小细胞肺癌的临床数据
2025-10-19 11:44:20
Check Details
1
2
...
9073
9074
9075
9076
9077
9078
9079
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Venetoclax (Venetoclax): Balancing Precision with Risk Management in Hematologic Malignancies
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
4
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
5
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
6
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
7
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
8
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
9
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
10
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
11
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
12
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management